Ellie Merle is a biotechnology equity research analyst. Prior to joining UBS, Ellie was a biotechnology analyst at Cantor Fitzgerald covering 15+ stocks in the small mid cap space. Prior to Cantor Fitzgerald, Ellie worked at Credit Suisse and Deutsche Bank as the senior associate on an II (Institutional Investor) ranked biotechnology team. Ellie attended Pomona College (BA in Economics) and is a CFA Charter holder. Ellie was born and raised in Brooklyn and outside of work, Ellie’s passions include her two dogs and exploring new restaurants.